Homozygous 2p11.2 deletion supports the implication of ELMOD3 in hearing loss and reveals the potential association of CAPG with ASD/ID etiology.


Journal

Journal of applied genetics
ISSN: 2190-3883
Titre abrégé: J Appl Genet
Pays: England
ID NLM: 9514582

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 20 08 2018
accepted: 27 09 2018
revised: 25 09 2018
pubmed: 5 10 2018
medline: 17 5 2019
entrez: 5 10 2018
Statut: ppublish

Résumé

Autism spectrum disorder (ASD) is a set of neurodevelopmental conditions characterized by early-onset difficulties in social communication and unusually restricted, repetitive behavior and interests. Parental consanguinity may lead to higher risk of ASD and to more severe clinical presentations in the offspring. Studies of ASD families with high inbreeding enable the identification of inherited variants of this disorder particularly those with an autosomal recessive pattern of inheritance. In our study, using copy number variants (CNV) analysis, we identified a rare homozygous deletion in 2p11.2 region that affects ELMOD3, CAPG, and SH2D6 genes in a boy with ASD, intellectual disability (ID), and hearing impairment (HI). This deletion may reveal a new contiguous deletion syndrome in which ELMOD3, known to be implicated in autosomal recessive deafness underlies the HI of the proband and CAPG, member of actin regulatory proteins involved in cytoskeletal dynamic, an important function for brain development and activity, underlies the ASD/ID phenotype. A possible contribution of SH2D6 gene, as a part of a chimeric gene, to the clinical presentation of the patient is discussed. Our result supports the implication of ELMOD3 in hearing loss and highlights the potential clinical relevance of 2p11.2 deletion in autism and/or intellectual disability.

Identifiants

pubmed: 30284680
doi: 10.1007/s13353-018-0472-3
pii: 10.1007/s13353-018-0472-3
doi:

Substances chimiques

ELMOD3 protein, human 0
GTPase-Activating Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

49-56

Références

J Cell Biol. 2001 Aug 20;154(4):775-84
pubmed: 11514591
Proc Natl Acad Sci U S A. 2004 May 18;101(20):7763-8
pubmed: 15128950
J Med Genet. 2006 Nov;43(11):843-9
pubmed: 16840569
Nucleic Acids Res. 2007;35(6):2013-25
pubmed: 17341461
Genome Res. 2007 Nov;17(11):1665-74
pubmed: 17921354
Science. 2008 Jul 11;321(5886):218-23
pubmed: 18621663
J Med Genet. 2010 Jan;47(1):22-9
pubmed: 19592390
J Cell Biol. 2010 May 17;189(4):619-29
pubmed: 20457765
Neuron. 2011 Jun 9;70(5):886-97
pubmed: 21658582
Sci Signal. 2011 Dec 06;4(202):ra83
pubmed: 22155787
Curr Opin Genet Dev. 2012 Jun;22(3):229-37
pubmed: 22463983
Child Dev. 2013 Jan-Feb;84(1):121-32
pubmed: 23311723
Neuron. 2013 Jan 23;77(2):235-42
pubmed: 23352160
Cell Adh Migr. 2013 Jul-Aug;7(4):379-87
pubmed: 23628914
PLoS Genet. 2013;9(9):e1003774
pubmed: 24039609
Am J Hum Genet. 2013 Oct 3;93(4):697-710
pubmed: 24094746
Nat Rev Neurosci. 2015 Sep;16(9):551-63
pubmed: 26289574
Ann Hum Genet. 2016 May;80(3):187-96
pubmed: 27000383
Nature. 2017 Apr 12;544(7649):235-239
pubmed: 28406212
Int J Genomics. 2017;2017:4798474
pubmed: 28630856
J Autism Dev Disord. 2018 Feb;48(2):442-449
pubmed: 29027068
Hum Genet. 2018 Apr;137(4):329-342
pubmed: 29713870
Genomics. 1994 Oct;23(3):560-5
pubmed: 7851883

Auteurs

Saida Lahbib (S)

Biomedical Genomics and Oncogenetics Laboratory LR16IPT05, Université Tunis El Manar, Institut Pasteur de Tunis, 1002, Tunis, Tunisia. saidalahbib89@gmail.com.
University of Tunis El Manar, Tunis, Tunisia. saidalahbib89@gmail.com.

Claire S Leblond (CS)

Human Genetics and Cognitive Functions Unit, Institut Pasteur, 75015, Paris, France.
CNRS UMR3571, Genes, Synapses and Cognition, Institut Pasteur, 75015, Paris, France.
Paris Diderot University, Sorbonne Paris Cité, 75013, Paris, France.

Mariem Hamza (M)

Faculty of Medicine of Tunis, University of Tunis El Manar, 1007 La Rabta, Tunis, Tunisia.
Child and Adolescent Psychiatry Department, Mongi Slim Hospital, 2046, Sidi Daoud, Tunisia.

Béatrice Regnault (B)

Plateforme de Génotypage des Eucaryotes, Centre d'Innovation et Recherche Technologique (CITECH), Institut Pasteur, 75015, Paris, France.

Laure Lemée (L)

Plateforme de Génotypage des Eucaryotes, Centre d'Innovation et Recherche Technologique (CITECH), Institut Pasteur, 75015, Paris, France.

Alexandre Mathieu (A)

Human Genetics and Cognitive Functions Unit, Institut Pasteur, 75015, Paris, France.
CNRS UMR3571, Genes, Synapses and Cognition, Institut Pasteur, 75015, Paris, France.
Paris Diderot University, Sorbonne Paris Cité, 75013, Paris, France.

Hager Jaouadi (H)

Biomedical Genomics and Oncogenetics Laboratory LR16IPT05, Université Tunis El Manar, Institut Pasteur de Tunis, 1002, Tunis, Tunisia.

Rahma Mkaouar (R)

Biomedical Genomics and Oncogenetics Laboratory LR16IPT05, Université Tunis El Manar, Institut Pasteur de Tunis, 1002, Tunis, Tunisia.

Ilhem Ben Youssef-Turki (IB)

Faculty of Medicine of Tunis, University of Tunis El Manar, 1007 La Rabta, Tunis, Tunisia.
Research Unit UR12 SP24 and Department of Child and Adolescent Neurology, National Institute Mongi Ben Hmida of Neurology, 1007, Tunis, Tunisia.

Ahlem Belhadj (A)

Faculty of Medicine of Tunis, University of Tunis El Manar, 1007 La Rabta, Tunis, Tunisia.
Child and Adolescent Psychiatry Department, Mongi Slim Hospital, 2046, Sidi Daoud, Tunisia.

Ichraf Kraoua (I)

Faculty of Medicine of Tunis, University of Tunis El Manar, 1007 La Rabta, Tunis, Tunisia.
Research Unit UR12 SP24 and Department of Child and Adolescent Neurology, National Institute Mongi Ben Hmida of Neurology, 1007, Tunis, Tunisia.

Thomas Bourgeron (T)

Human Genetics and Cognitive Functions Unit, Institut Pasteur, 75015, Paris, France.
CNRS UMR3571, Genes, Synapses and Cognition, Institut Pasteur, 75015, Paris, France.
Paris Diderot University, Sorbonne Paris Cité, 75013, Paris, France.

Sonia Abdelhak (S)

Biomedical Genomics and Oncogenetics Laboratory LR16IPT05, Université Tunis El Manar, Institut Pasteur de Tunis, 1002, Tunis, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH